RSEBX
Price
$70.45
Change
+$0.41 (+0.59%)
Updated
Jul 3 closing price
Net Assets
79.12B
SMCFX
Price
$75.39
Change
+$0.43 (+0.57%)
Updated
Jul 3 closing price
Net Assets
79.12B
Interact to see
Advertisement

RSEBX vs SMCFX

Header iconRSEBX vs SMCFX Comparison
Open Charts RSEBX vs SMCFXBanner chart's image
American Funds SMALLCAP World R2E
Price$70.45
Change+$0.41 (+0.59%)
VolumeN/A
Net Assets79.12B
American Funds SMALLCAP World F2
Price$75.39
Change+$0.43 (+0.57%)
VolumeN/A
Net Assets79.12B
RSEBX vs SMCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSEBX vs. SMCFX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSEBX is a Buy and SMCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSEBX (79.1B) and SMCFX (79.1B) have equal amount of cash in the bank . SMCFX pays higher dividends than RSEBX: SMCFX (0.83) vs RSEBX (0.23). RSEBX was incepted earlier than SMCFX: RSEBX (11 years) vs SMCFX (17 years). RSEBX (1.45) is less costly to investors than SMCFX (0.76). RSEBX (32.00) and SMCFX (32.00) have comparable annual turnover. RSEBX (250) and SMCFX (250) have matching initial minimum investment requirements. SMCFX annual gain was more profitable for investors over the last year : 10.67 vs. RSEBX (9.90). SMCFX return over 5 years is better than : 23.35 vs. RSEBX (18.70).
RSEBXSMCFXRSEBX / SMCFX
Total Expense Ratio1.450.76191%
Annual Report Gross Expense Ratio1.450.76191%
Fund Existence11 years17 years-
Gain YTD8.3738.73296%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets79.1B79.1B100%
Annual Yield % from dividends0.230.8328%
Returns for 1 year9.9010.6793%
Returns for 3 years33.3435.8693%
Returns for 5 years18.7023.3580%
Returns for 10 years41.2251.9279%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAGN13.180.11
+0.84%
Magnera Corporation
LGND114.580.92
+0.81%
Ligand Pharmaceuticals
SWKS78.760.58
+0.74%
Skyworks Solutions
BCAX9.03-0.17
-1.85%
Bicara Therapeutics Inc.
NTRP3.55-0.24
-6.33%
NextTrip